Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Editorial [Hot topic: Target Therapy of Bone Metastases and Tumours (Guest Editors: M. Caraglia and D. Santini)] promotion: free to download

Volume:9   Issue: 7
Pp: 789-790
Michele Caraglia and Daniele Santini
DOI: 10.2174/156800909789760429

Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects

Volume:9   Issue: 7
Pp: 791-800
M. Marra, A. Abbruzzese, R. Addeo, S. Del Prete, P. Tassone, G. Tonini, P. Tagliaferri, D. Santini and M. Caraglia
DOI: 10.2174/156800909789760285

Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases

Volume:9   Issue: 7
Pp: 834-842
D. Santini, M. E. Fratto, B. Vincenzi, N. Napoli, S. Galluzzo, M. Tantardini, A. Abbruzzese, M. Caraglia and G. Tonini
DOI: 10.2174/156800909789760375

Targeted Therapies in Bone Sarcomas

Volume:9   Issue: 7
Pp: 843-853
K. Scotlandi, P. Picci and H. Kovar
DOI: 10.2174/156800909789760410

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

Volume:9   Issue: 7
Pp: 854-870
P. Tassone, P. Tagliaferri, M. Rossi, T. Calimeri, A. Bulotta, A. Abbruzzese, M. Caraglia and P. Neri
DOI: 10.2174/156800909789760393